{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Long-Term Efficacy of Medication-Assisted Treatment of Opioid Addiction: A Systematic Literature Review - Part 2

Activity Steps


NOTE: This activity requires payment before viewing.

Purpose of Activity

To examine the evidence on long-term efficacy of medication-assisted treatment for opioid.

Learning Objectives/Outcomes

After completing this continuing education activity you will be able to:

  1. Describe the efficacy of full and partial opioid agonist medication-assisted treatment (MAT) in long-term patient outcomes.
  2. Summarize the aggregate research evidence concerning the relative efficacy of methadone versus buprenorphine/ buprenorphine-naloxone MAT on long-term patient outcomes.
  3. Explain the research evidence for the efficacy for injectable antagonist MAT on long-term patient outcomes.
Price: $49.00


  • ANCC 1.0 CH / 1.0 APH
  • DC - BON 1.0 CH
  • FL - BON 1.0 CH
  • GA - BON 1.0 CH

Lippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.

Awarded Advanced Pharmacology Hours

Test Code: TPM0220
Published: Feb 2020
Expires: 12/3/2021
Required Passing Score: 7/10 (70%)
Authors: Thomas Julian, MS, RN